Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
During this proposed clinical trial, the investigators intend to evaluate the pharmacodynamic
anti-inflammatory properties and safety of TPI ASM8, by investigating the effect on sputum
eosinophils and the airway responses during an allergen challenge at different dose levels.